[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352806-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352806-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mapping-the-function-of-ef-hand-domain-containing-protein-2-and-determining-its-clinical-relevance-in-non-small-cell-lung-cancer-through-single-cell-transcriptomics","Mapping the function of EF-hand domain-containing protein 2 and determining its clinical relevance in non-small-cell lung cancer through single-cell transcriptomics","","This research investigates cellular composition and transcriptional variability within the tumor microenvironment (TME) of non-small-cell lung cancer (NSCLC) using single-cell RNA sequencing, while evaluating the role of EF-hand domain-containing protein 2 (EFHD2) in tumor progression and related signaling pathways. Single-cell transcriptomic mapping was complemented with immunohistochemistry for EFHD2 expression and immune infiltration, and functional validation using Western blot, qRT-PCR, and cellular proliferation, migration, invasion, and apoptosis assays. JAK-STAT signaling was explored as a mechanistic basis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mapping-the-function-of-ef-hand-domain-containing-protein-2-and-determining-its-clinical-relevance-in-non-small-cell-lung-cancer-through-single-cell-transcriptomics/352806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mapping-the-function-of-ef-hand-domain-containing-protein-2-and-determining-its-clinical-relevance-in-non-small-cell-lung-cancer-through-single-cell-transcriptomics/352806.png","ImageObject",300,407,{"name":42,"@type":43},"Sarah ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study?","Question",{"text":63,"@type":64},"To characterize the NSCLC tumor microenvironment at single-cell resolution and determine how EFHD2 relates to tumor progression and signaling pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was EFHD2 expression validated in clinical samples?",{"text":68,"@type":64},"Immunohistochemistry (IHC) was used to confirm EFHD2 expression and assess immune cell infiltration in tumor versus adjacent non-tumor tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional and mechanistic methods were used to study EFHD2?",{"text":72,"@type":64},"Western blot and quantitative real-time PCR, along with proliferation, migration, invasion, and apoptosis assays, were performed, and the JAK-STAT signaling pathway was examined as a potential mechanism.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352806,1790182162,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[https://www.cytojournal.com/](https://www.cytojournal.com/)  \nCytoJournal  \nEditor-in-Chief:  \nDongge Liu, MD (Beijing Hospital, Beijing, China)  \nHe Wang, MD, PhD (Yale University School of Medicine, New Haven, Connecticut, USA)  \nFounding Editor & Editor-in-chief Emeritus:  \nVinod B. Shidham, MD, FIAC, FRCPath (WSU School of Medicine, Detroit, USA)  \nResearch Article  \nMapping the function of EF-hand domain-containing protein 2 and determining its clinical relevance in non-small-cell lung cancer through single-cell transcriptomics  \nXueping Luo, MM1, Feng Zhang, MM1, Zhiyu Li, MB1, Chucheng Zhong, MM1, Xiaozhen Shen, MM1* 1Department of Thoracic Surgery, Guangzhou Medical University Affiliated Fifth Hospital, Guangzhou, China.  \n*Corresponding author:  \nXiaozhen Shen, Department of Thoracic Surgery, Guangzhou Medical University Affiliated Fifth Hospital, Guangzhou, China.  \n[sxzjie@126.com](sxzjie@126.com)  \n\n| Received: 12 February 2025\u003Cbr>Accepted: 09 July 2025\u003Cbr>Published: 21 March 2026 |\n| --- |\n| DOI\u003Cbr>10.25259/Cytojournal_29_2025 |\n\nQuick Response Code:  \nABSTRACT  \nObjective: This study aims to explore the cellular composition and transcriptional variability within the tumor microenvironment (TME) of non-small-cell lung cancer (NSCLC) using single-cell RNA sequencing (scRNAseq) and to assess the role ofEF-hand domain-containing protein 2 (EFHD2) in tumor progression and its involvement in relevant signaling pathways.  \nMaterial and Methods: We analyzed scRNA-seq datasets to map the cellular and transcriptional landscape of NSCLC tumors. Immunohistochemistry (IHC) was employed to validate the expression of EFHD2 and assess immune cell infiltration in clinical samples. To further investigate the functional effect of EFHD2, we performed Western blot and quantitative real-time polymerase chain reaction analyses as well as cell proliferation, migration, invasion, and apoptosis assays. We also explored the janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling pathway as a potential underlying mechanism.  \nResults: The scRNA-seq analysis revealed that epithelial cells were the predominant population within the TME, alongside endothelial cells, fibroblasts, macrophages, and a small proportion of stem cells. EFHD2 expression exhibited considerable variability, with higher levels associated with clusters enriched in transcriptionally active and immunomodulatory pathways. The IHC results demonstrated elevated EFHD2 expression and immune cell infiltration in tumor tissues compared with adjacent non-tumor tissues.  \nConclusion: EFHD2 expression in the NSCLC TME correlates with immune cell infiltration and may playa significant role in tumor progression and immune modulation. The JAK-STAT signaling pathway may be a potential mechanism underlying the effect of EFHD2 . This work provides a new avenue for targeted therapy in NSCLC.  \nKeywords: EF-hand domain-containing protein 2, Janus Kinase-signal transducers and activators of transcription, Non-small-cell lung cancer, Single-cell RNA sequencing, Tumor microenvironment  \nINTRODUCTION  \nLung cancer remains as one of the cancers with high mortality rate worldwide, with non-smallcell lung cancer (NSCLC) accounting for about 85% of all lung cancer cases. [1] For advanced NSCLC without identified driver-gene mutations, immunotherapy, particularly through immune checkpoint blockade, is a primary treatment modality.[2,3] Neoadjuvant immunotherapy, which is  \nThis is an open-access article distributed under the terms of the Creative Commons Attribution-Non CommercialShare Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. © 2026 The Author(s) . Published by Scientific Scholar.  \nCytoJournal • 2026 • 23(21) | 1  \nadministered preoperatively, emerges as a highly promising strategy.[4,5] However, the average major","cbCairqYV5IL1UVT","https://ap.wps.com/l/cbCairqYV5IL1UVT","pdf",10713758,14,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To characterize the NSCLC tumor microenvironment at single-cell resolution and determine how EFHD2 relates to tumor progression and signaling pathways.\"},{\"question\":\"How was EFHD2 expression validated in clinical samples?\",\"answer\":\"Immunohistochemistry (IHC) was used to confirm EFHD2 expression and assess immune cell infiltration in tumor versus adjacent non-tumor tissues.\"},{\"question\":\"What functional and mechanistic methods were used to study EFHD2?\",\"answer\":\"Western blot and quantitative real-time PCR, along with proliferation, migration, invasion, and apoptosis assays, were performed, and the JAK-STAT signaling pathway was examined as a potential mechanism.\"}]","Mapping the function of EF-hand domain-containing protein 2 and determining its clinical relevance in non-small-cell lung cancer through single-cell transcriptomics | PDF",1790101465,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/125e1c02fa8b2d330573c8988c4aefbb.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/daa900e79b833fce4541792f287e24da.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00f3d67ad6d8d588893d455012f305b2.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1627a69a1a796058ec712c669a0838a0.webp",980,1268]